Life science research in China has made tremendous progress in recent years. DiaSys uses this drive since 2009 with an own research group at DiaSys Greater China working on the generation of recombinant proteins and monoclonal antibodies.
In a short time a large number of monoclonal cell lines were established and promising antibodies isolated. At present, these antibodies are characterized and examined for their potential for development of new diagnostic tests in close cooperation with R&D in Holzheim.
The Shanghai R&D team is excellently networked with local universities and research facilities and therefore up-to-date about newest research results. We are sure that already in the near future our Chinese colleagues will greatly contribute to the expansion of the DiaSys diagnostic test portfolio.